A detailed history of American Century Companies Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, American Century Companies Inc holds 2,263,743 shares of LLY stock, worth $1.8 Billion. This represents 1.2% of its overall portfolio holdings.

Number of Shares
2,263,743
Previous 2,069,881 9.37%
Holding current value
$1.8 Billion
Previous $1.87 Billion 7.02%
% of portfolio
1.2%
Previous 1.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $150 Million - $186 Million
193,862 Added 9.37%
2,263,743 $2.01 Billion
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $72.8 Million - $91.3 Million
100,426 Added 5.1%
2,069,881 $1.87 Billion
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $4.2 Million - $5.61 Million
-7,084 Reduced 0.36%
1,969,455 $1.53 Billion
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $1.04 Billion - $1.22 Billion
1,976,539 New
1,976,539 $1.15 Billion
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $129 Million - $178 Million
297,672 Added 18.26%
1,927,954 $1.04 Billion
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $40.5 Million - $54.1 Million
115,440 Added 7.62%
1,630,282 $765 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $106 Million - $124 Million
340,159 Added 28.96%
1,514,842 $520 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $185 Million - $216 Million
576,450 Added 96.36%
1,174,683 $430 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $31.3 Million - $35.7 Million
105,686 Added 21.46%
598,233 $193 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $125 Million - $147 Million
448,772 Added 1025.18%
492,547 $160 Million
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $720,263 - $895,104
-3,069 Reduced 6.55%
43,775 $12.5 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $3.68 Million - $4.56 Million
16,351 Added 53.62%
46,844 $12.9 Million
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $14.3 Million - $17.6 Million
-64,660 Reduced 67.95%
30,493 $7.05 Million
Q2 2021

Aug 05, 2021

BUY
$180.55 - $233.54 $9.78 Million - $12.6 Million
54,151 Added 132.07%
95,153 $21.8 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $763,430 - $988,297
4,646 Added 12.78%
41,002 $7.66 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $8.39 Million - $11.1 Million
-64,318 Reduced 63.89%
36,356 $6.14 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $6.33 Million - $7.32 Million
43,290 Added 75.44%
100,674 $14.9 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $1.45 Million - $1.74 Million
10,610 Added 22.68%
57,384 $9.42 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $599,773 - $742,349
5,038 Added 12.07%
46,774 $6.49 Million
Q4 2019

Feb 12, 2020

SELL
$106.92 - $132.43 $26.4 Million - $32.7 Million
-246,569 Reduced 85.52%
41,736 $5.49 Million
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $19.4 Million - $21.1 Million
-182,004 Reduced 38.7%
288,305 $32.2 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $11.9 Million - $13.9 Million
107,268 Added 29.55%
470,309 $52.1 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $4.05 Million - $4.77 Million
-36,394 Reduced 9.11%
363,041 $0
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $661,663 - $741,262
6,248 Added 1.59%
399,435 $46.2 Million
Q3 2018

Nov 02, 2018

SELL
$85.86 - $107.31 $4.21 Million - $5.27 Million
-49,084 Reduced 11.1%
393,187 $42.2 Million
Q2 2018

Aug 08, 2018

SELL
$75.7 - $86.88 $74.3 Million - $85.3 Million
-981,464 Reduced 68.94%
442,271 $37.7 Million
Q1 2018

May 03, 2018

SELL
$74.21 - $87.6 $7.7 Million - $9.09 Million
-103,774 Reduced 6.79%
1,423,735 $110 Million
Q4 2017

Feb 02, 2018

SELL
$81.94 - $87.89 $58.6 Million - $62.9 Million
-715,357 Reduced 31.89%
1,527,509 $129 Million
Q3 2017

Nov 01, 2017

BUY
$77.07 - $85.54 $173 Million - $192 Million
2,242,866
2,242,866 $192 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.